Cargando…

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals

OBJECTIVE: Diagnostic evaluation of the ID NOW coronavirus disease 2019 (COVID-19) assay in various real-world settings among symptomatic and asymptomatic individuals. METHODS: Depending on the setting, the ID NOW testing was performed using oropharyngeal swabs (OPSs) taken from patients with sympto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stokes, William, Venner, Allison A., Buss, Emily, Tipples, Graham, Berenger, Byron M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463071/ https://www.ncbi.nlm.nih.gov/pubmed/36096431 http://dx.doi.org/10.1016/j.cmi.2022.08.025

Ejemplares similares

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff
por: Kanji, Jamil N., et al.
Publicado: (2021)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Performance of Abbott ID‐Now rapid nucleic amplification test for laboratory identification of COVID‐19 in asymptomatic emergency department patients
por: Ramachandran, Anu, et al.
Publicado: (2021)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR
por: Srivastava, Smriti, et al.
Publicado: (2022)

678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients
por: Murphy, Catherine, et al.
Publicado: (2021)

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting
por: Graham, Maryza, et al.
Publicado: (2021)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test
por: Aupaix, Antoine, et al.
Publicado: (2021)

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
por: Barnacle, J.R., et al.
Publicado: (2022)

Application of Abbott ID NOW in the emergency department for SARS-CoV-2 detection: A medical center’s perspective
por: Fan, Shu-Ling
Publicado: (2023)

Performance of the Abbott ID NOW rapid SARS-CoV-2 amplification assay in relation to nasopharyngeal viral RNA loads
por: Sepulveda, Jorge L., et al.
Publicado: (2021)

Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario
por: Deslandes, Vincent, et al.
Publicado: (2022)

Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery
por: Babic, N., et al.
Publicado: (2023)

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs
por: Serei, Virian D., et al.
Publicado: (2021)

Comparative Evaluation of Cartridge-Based Abbott ID NOW Test With Probe-Based Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of SARS-CoV-2
por: Pattnaik, Dipti, et al.
Publicado: (2022)

Compendio Abbott.
Publicado: (1953)

Abbott’s at the Top
Publicado: (1909)

Abbott’s Scissors
Publicado: (1883)

Abbott’s Scissors
Publicado: (1884)

Evaluation of the COVID19 ID NOW EUA assay
por: Mitchell, Stephanie L., et al.
Publicado: (2020)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19
por: Rhoads, Daniel D., et al.
Publicado: (2020)

Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
por: Basu, Atreyee, et al.
Publicado: (2020)

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department
por: Bousquet, Aurore, et al.
Publicado: (2022)

Dr. Frank Abbott
por: Tension, W. D., et al.
Publicado: (1897)

Dr. George Abbott
Publicado: (1911)

Abbott’s History of the Rebellion
Publicado: (1863)

Professor Frank Abbott
Publicado: (1897)

Professor Frank Abbott
Publicado: (1897)

Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic
por: Wang, Yutong, et al.
Publicado: (2022)

Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
por: Siddiqui, Zishan K., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sqvd6lqmre5gnhnv3bnufgrj0u